The existing evidence above emphasized the great importance of SLC7A11 in modulating ferroptosis in ovarian cancer, hence a better understanding of the regulatory mechanism of SLC7A11 on the initiation and development of ferroptosis is urgently required to help us develop effective therapeutics in ovarian cancer. This evidence concerns the gene SLC7A11 and ovarian carcinoma.